Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Merck Frosst and AxyS team claims novel cathepsin K inhibitors in recent patent

June 16, 2003

BPC-157 promotes healing of bone and muscle in preclinical models

June 16, 2003

Improved glycemic control found for liraglutide in obese patients with type 2 diabetes

June 13, 2003

Preclinical data on oleoyl-estrone presented in Helsinki

June 13, 2003

T-614 stimulates bone formation in vitro and in vivo

June 13, 2003

AMG-162, a human MAb against RANKL, suppresses bone resorption in monkeys

June 12, 2003

New approvals for Prempro

June 12, 2003

New orexin OX-1 antagonists, their preparation and use reported by GSK researchers

June 12, 2003

Raloxifene increases bone mineral density in Chinese women

June 12, 2003

HMR-1426: a potent orally active anoretic

June 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...